NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rivia

Rivia

Private
ZurichHealthcare & Life Scienceshttps://www.rivia.com/

Last Round

Series A

Mar 18, 2026

Total Funding Raised

$18.23M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Rivia is a software company that provides a unified data and AI analytics platform for biotech clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Data Integration, Business Intelligence, Healthcare Analytics, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical trial softwareclinical data managementeclinicalclinical trial analyticsAI agentsagentic workflowdata harmonizationclinical trial monitoringconversational AIbiotech softwareclinical operationsSaaS platformdata integrationdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rivia Comparables

Compare Rivia with similar companies based on industry and business-model similarity.

Rivia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProofPilot
76%
eClinical Solutions
75%
Maxis AI
74%

Rivia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 18, 2026
SeedJun 12, 2024

Key People

Founding team and executive leadership

Henk Johan Streefkerk

Chief Medical Officer & Co-Founder

Founding Team

Tiago Kieliger

Co-founder & CTO

Founding Team

Erik Scalfaro

Co-Founder & CEO

Founding Team

Rivia Investors

Notable investors and investment history

Rivia investors
InvestorRounds
DefiantSeries A
Nina CapitalSeries A, Seed
Amino CollectiveSeries A, Seed
SpeedinvestSeries A, Seed
Earlybird Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2026

    Grew 25% quarter-over-quarter, from 20 to 25 employees.

  • May 14, 2026

    Grew 32% QoQ, from 19 to 25 employees.

Rivia Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rivia Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rivia's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range25
Year Founded2022
Last FundingMar 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.